Cryo-Cell International, Inc. (NYSEAMERICAN:CCEL) Plans $0.25 — Dividend

Cryo-Cell International, Inc. (NYSEAMERICAN:CCEL) declared a — dividend on Wednesday, October 30th,Wall Street Journal reports. Stockholders of record on Friday, November 15th will be paid a dividend of 0.25 per share on Friday, November 29th. The ex-dividend date of this dividend is Friday, November 15th.

Cryo-Cell International has a dividend payout ratio of 833.3% indicating that the company cannot currently cover its dividend with earnings alone and is relying on its balance sheet to cover its dividend payments.

Cryo-Cell International Price Performance

Shares of NYSEAMERICAN CCEL opened at $9.33 on Wednesday. The company has a market cap of $75.20 million, a PE ratio of 17.13 and a beta of 0.43. Cryo-Cell International has a 12-month low of $3.67 and a 12-month high of $9.50.

Cryo-Cell International (NYSEAMERICAN:CCEL) last issued its quarterly earnings data on Tuesday, October 15th. The company reported $0.13 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.02 by $0.11. The business had revenue of $8.07 million during the quarter. Cryo-Cell International had a negative return on equity of 42.06% and a negative net margin of 28.03%.

Cryo-Cell International Company Profile

Cryo-Cell International, Inc engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, auto-immune diseases, multiple sclerosis, Alzheimer's disease, Parkinson's diseases.